Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 88

Results For "United-States"

1047 News Found

SoftBank Robotics takes a five per cent stake in Avalon SteriTech
Digitisation | April 20, 2022

SoftBank Robotics takes a five per cent stake in Avalon SteriTech

Strive to empower public health with disinfection robotics solutions in post-pandemic era


Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets
Drug Approval | April 18, 2022

Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets

This product will be manufactured at Lupin’s Nagpur facility in India


Lupin receives approval from USFDA for Desvenlafaxine extended-release tablets 25 mg
Drug Approval | April 15, 2022

Lupin receives approval from USFDA for Desvenlafaxine extended-release tablets 25 mg

The product will be manufactured at Lupin’s facility in Goa, India


Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis
Healthcare | April 13, 2022

Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis

The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa


Cambrex completes large-scale US API expansion
Biotech | April 12, 2022

Cambrex completes large-scale US API expansion

The expansion positions Cambrex with the largest and most advanced API facility in the United States


Pancreatic cancer lab-grown human organoids may predict effective chemotherapy treatment
Biotech | April 08, 2022

Pancreatic cancer lab-grown human organoids may predict effective chemotherapy treatment

Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting


Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer
Biotech | April 08, 2022

Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer

The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC


Hataali wins US patent for the use of blockchain in advanced medicinal therapy
Digitisation | April 06, 2022

Hataali wins US patent for the use of blockchain in advanced medicinal therapy

The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award


USFDA seeks more analysis on Merck’s BLA for Vaxneuvance
Biotech | April 01, 2022

USFDA seeks more analysis on Merck’s BLA for Vaxneuvance

No new studies have been requested


GenScript wins Best CDMO award for the third time
News | March 30, 2022

GenScript wins Best CDMO award for the third time

The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".